GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Equity-to-Asset

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Equity-to-Asset : 0.30 (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. GlaxoSmithKline Consumer Nigeria's Total Stockholders Equity for the quarter that ended in Jun. 2023 was ₦9,214 Mil. GlaxoSmithKline Consumer Nigeria's Total Assets for the quarter that ended in Jun. 2023 was ₦30,268 Mil. Therefore, GlaxoSmithKline Consumer Nigeria's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was 0.30.

The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's Equity-to-Asset or its related term are showing as below:

NSA:GLAXOSMITH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.3   Med: 0.46   Max: 0.68
Current: 0.3

During the past 13 years, the highest Equity to Asset Ratio of GlaxoSmithKline Consumer Nigeria was 0.68. The lowest was 0.30. And the median was 0.46.

NSA:GLAXOSMITH's Equity-to-Asset is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.58 vs NSA:GLAXOSMITH: 0.30

GlaxoSmithKline Consumer Nigeria Equity-to-Asset Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Equity-to-Asset Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.49 0.38 0.35 0.32

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.34 0.32 0.32 0.30

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Equity-to-Asset

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Equity-to-Asset falls into.



GlaxoSmithKline Consumer Nigeria Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

GlaxoSmithKline Consumer Nigeria's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=9532.452/29386.204
=0.32

GlaxoSmithKline Consumer Nigeria's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )=Total Stockholders Equity/Total Assets
=9214.442/30268.016
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


GlaxoSmithKline Consumer Nigeria Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines